• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    HUTCHMED Highlights Sovleplenib, Hematology Data At Upcoming EHA 2024

    16 May 2024 //

    GLOBENEWSWIRE

    Hutchmed Announces NDA Acceptance in China for Sovleplenib

    10 Jan 2024 //

    GLOBENEWSWIRE

    Sovleplenib Elicits Durable Responses in Primary Immune Thrombocytopenia

    24 Aug 2023 //

    ONCLIVE

    HUTCHMED Announces that Sovleplenib PIII ESLIM-01 Study Met Its Primary Endpoint

    21 Aug 2023 //

    GLOBENEWSWIRE

    HUTCHMED Completes Patient Enrollment of ESLIM-01, a Ph III Trial of Sovleplenib

    03 Jan 2023 //

    GLOBENEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.